CD207 and lip and oral cavity carcinoma: Our study investigated the distribution profile of the DCs in OSMF, OSMF-OSCC, OL, and OSCC and revealed a significant decrease of CD1a+ and CD207+ cells in oral cancer and OSMF, but not for CD303 positive cells.